Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Elsa Mendoza has been living with the disease for years. Here's more on her battle and what it means to have Multiple ...

Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.

The agency identified six cases in Sanofi’s phase 3 program that met Hy’s Law—a rule of thumb for assessing the risk of ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Cold weather can significantly worsen multiple sclerosis symptoms, triggering stiffness, fatigue, and reduced mobility.

The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.

Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...